Determinants of adverse pregnancy outcomes among Sickle Cell Disease deliveries at a tertiary hospital in Tanzania from 1999 to 2011


Purpose: Sub-Saharan Africa has the world’s largest burden of Sickle Cell Disease (SCD), but due to poor care of SCD in childhood most do not reach reproductive ages. Consequently, due to sporadic cases of SCD in pregnancy, there has been little research attention to the problem in this sub region. This is one of the largest study series of SCD deliveries in Sub-Saharan Africa that aimed to establish the incidence and determinants of adverse pregnancy outcomes. Methods: Data of all deliveries from 1999 to 2011 at Muhimbili National Hospital (MNH) in Tanzania were analyzed. Deliveries of SCD were obtained and categorized according to presence or absence of adverse pregnancy outcomes based on set composite criteria. Using IBM SPSS statistics version 19, bivariate and multivariate logistic regression analyses were done to determine factors that were independently associated with adverse pregnancy outcomes. Statistics with p-value < 0.05 were taken as significant. Results: There were 157,473 deliveries during the study period of which 149 were by SCD mothers. The incidence of adverse pregnancy outcomes was 624 per 1000 SCD deliveries. Compared to SCD without adverse outcomes, those with adverse outcomes were more likely to be referred from lower health facilities (37% versus 12.5%, P = 0.001), of lower mean gestation age (36.3 ± 2.3 versus 38.4 ± 1.4, P < 0.001), more prematurity rate (50.7% versus 10.5%, P < 0.001), made lower mean number of antenatal visits (4.7 ± 2.2 versus 6.2 ± 2.4, P < 0.001) and delivered by cesarean section (31.2% versus 19.6%, P < 0.001). After adjusting for confounding factors, the odds of adverse outcomes were independently increased with referred compared to non-referred women (OR = 4.4; 95% CI: 1.2 - 16.8) and among Cesarean section deliveries compared to vaginal deliveries (OR = 4.2; 95% CI: 1.2 - 14.6). The risk of adverse outcomes decreased as the gestation age increased (OR = 0.4; 95% CI: 0.3 - 0.6). Conclusion: The incidence of adverse pregnancy outcomes in SCD is unacceptably high mainly contributed by poor management and prematurity.

Share and Cite:

Muganyizi, P. (2013) Determinants of adverse pregnancy outcomes among Sickle Cell Disease deliveries at a tertiary hospital in Tanzania from 1999 to 2011. Open Journal of Obstetrics and Gynecology, 3, 466-471. doi: 10.4236/ojog.2013.36086.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Serjeant, G.R. (2010) One hundred years of sickle cell disease. British Journal of Haematology, 151, 425-429. doi:10.1111/j.1365-2141.2010.08419.x
[2] Diallo, D. and Tchernia, G. (2002) Sickle cell disease in Africa. Current Opinion in Hematology, 9, 111-116. doi:10.1097/00062752-200203000-00005
[3] Wierenga, K.J., Hambleton, I.R. and Lewis, N.A. (2001) Survival estimates for patients with homozygous sicklecell disease in Jamaica: A clinic-based population study. Lancet, 357, 680-683. doi:10.1016/S0140-6736(00)04132-5
[4] Quinn, C.T., Rogers, Z.R. and Buchanan, G.R. (2004) Survival of children with sickle cell disease. Blood, 103, 4023-4027. doi:10.1182/blood-2003-11-3758
[5] Afolabi, B.B., et al. (2009) Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: A case control study. Journal of Obstetrics & Gynaecology, 29, 104-106. doi:10.1080/01443610802667112
[6] Al Jama, F.E., et al. (2009) Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, Eastern Saudi Arabia. Archives of Gynecology and Obstetrics, 280, 793-797. doi:10.1007/s00404-009-1002-7
[7] Asnani, M.R., McCaw-Binns, A.M. and Reid, M.E. (2011) Excess risk of maternal death from sickle cell disease in Jamaica: 1998-2007. PLoS ONE, 6, e26281. doi:10.1371/journal.pone.0026281
[8] Barfield, W.D., et al. (2010) Sickle cell disease and pregnancy outcomes: Women of African descent. American Journal of Preventive Medicine, 38, S542-S549. doi:10.1016/j.amepre.2009.12.020
[9] Rajab, K.E. and Skerman, J.H. (2004) Sickle cell disease in pregnancy. Obstetric and anesthetic management perspectives. SAUDI Medical Journal, 25, 265-276.
[10] Serjeant, G.R. (2005) Mortality from sickle cell disease in Africa. British Medical Journal, 330, 432-433. doi:10.1136/bmj.330.7489.432
[11] Serjeant, G.R., et al. (2004) Outcome of pregnancy in homozygous sickle cell disease. Obstetrics & Gynecology, 103, 1278-1285. doi:10.1097/01.AOG.0000127433.23611.54
[12] Smith, J.A., et al. (1996) Pregnancy in sickle cell disease: Experience of the cooperative study of sickle cell disease. Obstetrics & Gynecology, 87, 199-204. doi:10.1016/0029-7844(95)00367-3
[13] Sun, P.M., et al. (2001) Sickle cell disease in pregnancy: Twenty years of experience at Grady Memorial Hospital, Atlanta. American Journal of Obstetrics & Gynecology, 184, 1127-1130. doi:10.1067/mob.2001.115477
[14] Chakravarty, E.F., Khanna, D. and Chung, L. (2008) Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstetrics & Gynecology, 111, 927-934. doi:10.1097/01.AOG.0000308710.86880.a6
[15] Serjeant, G.R., Hambleton, I. and Thame, M. (2005) Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth. BJOG: An International Journal of Obstetrics & Gynaecology, 112, 1308-14. doi:10.1111/j.1471-0528.2005.00678.x
[16] Ogedengbe, O.K. and Akinyanju, O. (1993) The pattern of sickle cell disease in pregnancy in Lagos, Nigeria. West African Journal of Medicine, 12, 96-100.
[17] Dare, F.O., Makinde, O.O. and Faasuba, O.B. (1992) The obstetrics performance of sickle cell disease patients and homozygous C disease patients in Ile-Ife, Nigeria. International Journal of Gynecology & Obstetrics, 37, 163. doi:10.1016/0020-7292(92)90376-T
[18] Rahimy, M.C., et al. (2000) Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting. Blood, 96, 1685-1689.
[19] el-Shafei, A.M., Sandhu, A.K. and Dhaliwal, J.K. (1988) Maternal mortality in Bahrain with special reference to sickle cell disease. Australian and New Zealand Journal of Obstetrics and Gynaecology, 28, 41-44. doi:10.1111/j.1479-828X.1988.tb01609.x
[20] Simms-Stewart, D., et al. (2009) Retained placenta in homozygous sickle cell disease. Obstetrics & Gynecology, 114, 825-828. doi:10.1097/AOG.0b013e3181b6f762
[21] Villers, M.S., et al. (2008) Morbidity associated with sickle cell disease in pregnancy. American Journal of Obstetrics & Gynecology, 199, 125.
[22] Rees, D.C., et al. (2003) Guidelines for the management of the acute painful crisis in sickle cell disease. British Journal of Haematology, 120, 744-752. doi:10.1046/j.1365-2141.2003.04193.x
[23] Stuart, M.J. and Nagel, R.L. (2004) Sickle-cell disease. Lancet, 364, 1343-1360.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.